We are live on ! Find out more
Bank of New York Mellon

Bank of New York Mellon Portfolio holdings

AUM $609B
1-Year Est. Return 40.19%
 

Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.

This Fund
S&P 500
This Quarter Est. Return
+8.51%
1 Year Est. Return
+40.19%
3 Year Est. Return
+118.86%
5 Year Est. Return
+156%
10 Year Est. Return
+606.23%
AUM
$517B
AUM Growth
+$27.6B
Cap. Flow
-$8.37B
Cap. Flow %
-1.62%
Top 10 Hldgs %
19.4%
Holding
4,590
New
277
Increased
1,772
Reduced
2,129
Closed
201

Top Sells

Rank Stock Value
1
FERG icon
Ferguson
FERG
+$692M
2
LIN icon
Linde
LIN
+$624M
3
MDT icon
Medtronic
MDT
+$527M
4
GS icon
Goldman Sachs
GS
+$340M
5
MSFT icon
Microsoft
MSFT
+$301M

Sector Composition

Rank Sector Weight
1 Technology 25.11%
2 Healthcare 13.18%
3 Financials 12.45%
4 Consumer Discretionary 10.8%
5 Communication Services 8.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBT
4001
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
$171K ﹤0.01%
37,604
-48,701
-56% -$237K
DMAC icon
4002
DiaMedica Therapeutics
DMAC
$364M
$170K ﹤0.01%
38,284
-2,292
-6% -$18.8K
UBX
4003
DELISTED
Unity Biotechnology
UBX
$169K ﹤0.01%
3,639
-6,915
-66% -$333K
ANIX icon
4004
Anixa Biosciences
ANIX
$109M
$168K ﹤0.01%
43,302
-7,640
-15% -$32.5K
KEP icon
4005
Korea Electric Power
KEP
$14.8B
$168K ﹤0.01%
+15,532
New +$171K
AEG icon
4006
Aegon
AEG
$13.9B
$166K ﹤0.01%
42,914
+2,131
+5% +$9.07K
LABP
4007
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$162K ﹤0.01%
1,403
+385
+38% +$42.9K
EMD
4008
Western Asset Emerging Markets Debt Fund
EMD
$612M
$161K ﹤0.01%
11,487
-1,618
-12% -$22.3K
AG icon
4009
First Majestic Silver
AG
$9.26B
$159K ﹤0.01%
+10,084
New +$168K
LUMO
4010
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$159K ﹤0.01%
15,961
-748
-4% -$8.33K
JQC icon
4011
Nuveen Credit Strategies Income Fund
JQC
$715M
$158K ﹤0.01%
+23,324
New +$154K
ASYS icon
4012
Amtech Systems
ASYS
$280M
$156K ﹤0.01%
16,180
-1,262
-7% -$12.9K
VINC
4013
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$156K ﹤0.01%
+601
New +$183K
EGY icon
4014
Vaalco Energy
EGY
$592M
$154K ﹤0.01%
47,287
LPCN icon
4015
Lipocine
LPCN
$17M
$154K ﹤0.01%
6,483
+3,236
+100% +$76.1K
ROOT icon
4016
Root
ROOT
$772M
$154K ﹤0.01%
791
-63
-7% -$11.9K
SBBP
4017
DELISTED
Strongbridge Biopharma plc.
SBBP
$154K ﹤0.01%
51,948
-113,597
-69% -$300K
ABEO icon
4018
Abeona Therapeutics
ABEO
$361M
$153K ﹤0.01%
3,916
-7,053
-64% -$288K
OXY.WS icon
4019
Occidental Petroleum Corp Warrants
OXY.WS
$33.7B
$153K ﹤0.01%
11,040
-1,264
-10% -$14.6K
RESN
4020
DELISTED
Resonant Inc.
RESN
$152K ﹤0.01%
47,239
-113,735
-71% -$391K
PBIP
4021
DELISTED
Prudential Bancorp, Inc.
PBIP
$150K ﹤0.01%
10,803
-20,587
-66% -$287K
AMPY icon
4022
Amplify Energy
AMPY
$200M
$149K ﹤0.01%
36,733
-4,095
-10% -$13.6K
PHX
4023
DELISTED
PHX Minerals
PHX
$149K ﹤0.01%
40,042
EARN
4024
Ellington Residential Mortgage REIT
EARN
$167M
$147K ﹤0.01%
12,482
-24,324
-66% -$301K
HYT icon
4025
BlackRock Corporate High Yield Fund
HYT
$1.37B
$145K ﹤0.01%
+11,825
New +$142K

Similar funds

Bank of New York Mellon's Q2 2021 Portfolio in Review

As of Q2 2021, Bank of New York Mellon held 4,590 positions worth $517B, up 5.6% from $489B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Bank of New York Mellon's Q2 2021 filing shows 277 new, 1,772 increased, 2,129 reduced and 201 closed positions. Its largest new stake was Organon & Co: 4,240,135 shares worth $128M. The largest sale was Ferguson, an estimated $692M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • Bank of New York Mellon's largest Q2 2021 buy was Organon & Co: 4,240,135 shares worth $128M.
  • Bank of New York Mellon added most to Vanguard FTSE Developed Markets ETF in Q2 2021, an estimated $307M increase.
  • Bank of New York Mellon's biggest Q2 2021 reduction was Ferguson, cutting an estimated $692M.
  • Bank of New York Mellon fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $164M.
  • Bank of New York Mellon's ten largest holdings make up 19% of its $517B portfolio in Q2 2021.
  • Bank of New York Mellon opened 277 new positions and closed 201 in Q2 2021.
  • Bank of New York Mellon's portfolio value rose 5.6% quarter-over-quarter to $517B.

Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.